FinancialNeuro

Nevro sets range for IPO of up to $106m

October 28, 2014 by Brad Perriello

Nevro Corp. sets the per-share price range for its pending initial public offering, which would raise more than $106 million at the high end.

Nevro Corp. set the price range for its forthcoming initial public offering, which would raise $106.3 million at the high end of the range.

Menlo Park, Calif.-based Nevro plans to trade on the NASDAQ exchange under the symbol NVRO, according to a regulatory filing.

Nevro makes an implantable spinal cord stimulation system designed to treat chronic pain it calls Senza. Yesterday the company said it would issue 6.25 million shares at $15 to $17 apiece in the IPO, 1st announced earlier this month. That would mean proceeds of between $93.8 million and $106.3 million, or $100 million at the midpoint of the range.

READ THE REST AT MASSDEVICE

Print Friendly, PDF & Email
Tags

Josh Sandberg

Josh Sandberg is the President of Ortho Spine Partners and Partner for The De Angelis Group. He also serves as Co-Founder and Editor of OrthoSpineNews.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button
Close